Anika Therapeutics Inc.
ANIK - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$280.37M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $280.37 Million |
|---|---|
| Enterprise Value | $265.28 Million |
| Earnings per Share | $-0.76 |
| Beta | 0.21 |
| Outstanding Shares | 13,430,000 |
Return
| Return on Equity | -1.66% |
|---|---|
| Return on Assets | -1.24% |
| Return on Invested Capital | -0.85% |
Valuation & Multiples
| P/E Ratio | -77.74 |
|---|---|
| PEG | 42.4 |
| Price to Sales | 2.55 |
| Price to Book Ratio | 2.04 |
| Enterprise Value to Revenue | 2.2 |
| Enterprise Value to EBIT | -194.06 |
| Enterprise Value to Net Income | -117 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 4, 2026
EPS Estimate
$0.42
Consensus analyst estimateRevenue Estimate
$29.44 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 4.40%▼ 86.88% |
|---|---|
| Total Invested | $11.62M▼ 93.59% |
| Investors Holding | 29▼ 106.00% |
About Anika Therapeutics Inc.
CEO: Joseph Darling
